Pharmacological Therapies for Unconjugated Hyperbilirubinemia

E-ISSN： 1873-4286|15|25|2927-2938

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.25, 2009-09, pp. : 2927-2938

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Schizophrenia and Idiopathic Unconjugated Hyperbilirubinemia (Gilbert's Syndrome)

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 8, Iss. 4, 2008-12 ,pp. : 257-259

Bentham Science Publishers

Access to resources Recommend Favorite

Bilirubin and the Genome: The Hereditary Basis of Unconjugated Neonatal Hyperbilirubinemia

Current Pharmacogenomics, Vol. 3, Iss. 1, 2005-03 ,pp. : 21-42

Bentham Science Publishers

Access to resources Recommend Favorite

Rheumatoid arthritis: developing pharmacological therapies

By Moreland Larry W Misischia Richard J

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 7, 2002-07 ,pp. : 927-935

Informa Healthcare

Access to resources Recommend Favorite

Rheumatoid arthritis: developing pharmacological therapies

By Abbott Joel D Moreland Larry W

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 8, 2004-08 ,pp. : 1007-1018

Informa Healthcare

Access to resources Recommend Favorite

Emerging pharmacological therapies for erectile dysfunction

By Gingell J. Lockyer R.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 12, 1999-12 ,pp. : 1689-1696

Informa Healthcare

Access to resources Recommend Favorite